Kugabanya ibiro Semaglutide CAS 910463-68-2
Ibisobanuro
Semaglutide (910463-68-2) ni imiti irwanya diyabete igurishwa ku mazina nka Ozempic, Wegovy, na Rybelsus.Ikoreshwa mu kuvura diyabete yo mu bwoko bwa 2 no gucunga ibiro bidakira.Imiti ikora isa na glucagon yumuntu nka peptide-1 (GLP-1) mukongera insuline ya insuline, bigatuma habaho isukari ya metabolisme.Ikwirakwizwa nk'inshinge zapimwe munsi yikaramu yuzuye, cyangwa nkuburyo bwo munwa.Kimwe mu byiza byacyo kuruta indi miti igabanya ubukana ni uko ifite igihe kirekire cyo gukora, bityo, inshinge imwe mu cyumweru irahagije.
Gukoresha
Semaglutide ikoreshwa mugucunga diyabete yo mu bwoko bwa 2 hamwe nimpinduka zubuzima, nko guhagarika imirire no kongera imyitozo ngororamubiri.Ikora kandi mugutinda kugenda kwibiryo binyuze mu gifu kandi irashobora kugabanya ubushake bwo kurya no gutera ibiro.Nta raporo yatangajwe yerekana hepatotoxicity yitiriwe semaglutide ivura.
Uburyo bwibikorwa
Semaglutide ni glucagon isa na peptide-1 reseptor agonist.Yongera umusaruro wa insuline, imisemburo igabanya urugero rwisukari mu maraso.Bigaragara kandi kuzamura imikurire ya β selile muri pancreas, arizo mbuga za insuline.Irabuza kandi glucagon, imisemburo yongera isukari mu maraso.Byongeye kandi bigabanya gufata ibiryo bigabanya ubushake bwo kurya no kugabanya igogorwa ryigifu.Muri ubu buryo bigabanya ibinure byumubiri.
Igikorwa cyibinyabuzima
Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), analogue ikora glucagon imeze nka peptide 1 (GLP-1), ni agoniste ya GLP-1 ifite ubushobozi bwo kuvura indwara ya diyabete yo mu bwoko bwa 2 (T2DM).
Gupakira & Gutanga
